Sunil Raju

Sunil Raju has extensive experience in the pharmaceutical industry. Sunil most recently served as the Vice President of Clinical Development at UroGen Pharma since August 2022. Prior to that, they held the position of Vice President and Head of Drug Safety & Pharmacovigilance at Arcturus Therapeutics from March 2021 to July 2022.

Before joining Arcturus Therapeutics, Sunil Raju worked at UroGen Pharma, where they held various roles from 2019 to 2021. These roles include Vice President of Clinical Development and Pharmacovigilance, Head of Pharmacovigilance & Senior Director of Clinical Development, and Head of Pharmacovigilance & Senior Director.

Sunil Raju also has a significant tenure at Pfizer, where they worked from 2007 to 2018. During their time at Pfizer, they served as a Sr Director & Safety Risk Lead, Senior Director & Therapeutic Area Head, Medical Director, Medical Manager for Europe, Canada, Australia & New Zealand, and Medical Advisor.

Overall, Sunil Raju's work experience showcases their expertise in clinical development, pharmacovigilance, and drug safety within the pharmaceutical industry.

Sunil Raju attended Imperial College London from 1995 to 2001, where they obtained a degree in Medicine (MBBS) with a focus in the field of study being Medicine. Additionally, from 1999 to 2000, they pursued a Bachelor of Science degree in Management at the same institution.